Gilmore is set to save up to 40% on the cost of more than 300 medicine brands

Gilmore is set to save up to 40% on the cost of more than 300 medicine brands thanks to the Federal Government’s commitment to strengthening the Pharmaceutical Benefits Scheme (PBS).

Member for Gilmore, Ann Sudmalis said the Turnbull Government is committed to building better health care for Australians.

“New and expanded medicine listings to treat diabetes, cancer, arthritis, asthma and eye disease will also be available for a maximum of $39.50 or just $6.40 for concessional patients,” she said.

“We understand every single dollar matters and that is why we are reducing the cost of hundreds of important medicines.”

Since coming into Government, the Coalition has helped improve the health of Australians by subsidising more new medicines.

“Unlike Labor, we are cutting the cost of all drugs recommended by the Pharmaceutical Benefits Advisory Committee.

“Labor delayed the listing of seven vital drugs – leaving important medicines out of reach for many Gilmore patients.

“Our commitment to the PBS is rock solid. Together with Medicare, it is a foundation of a quality health care system, said Mrs Sudmalis.

Price reductions and new and expanded medicine listings came into effect on 1 April 2018. Media Release

#latest #Community #Federal #LocalStateFederal


COMMENTS : You can use a pen name or better yet use your real name, you must provide a valid email address (that does not get published) and your comment will be moderated prior to approval (or rejection if that is the determination of the moderator). Refer to our Terms and Conditions if you have any questions) 

Please note that from time to time comments are archived. If you are looking for a previous comment no longer visible please contact us. Last Archived 7th July 2019